Routine screening and support for emotional health in adults with type 2 diabetes
Official title: ARISE: Achieving Routine Intervention and Screening for Emotional Health: Randomized Controlled Trial
Run by University of Chicago · NCT06887049 · Data updated 2026-11-12
This project will test whether routine screening for diabetes-related emotional distress plus brief clinic training helps adults with type 2 diabetes and A1C over 8% feel less distressed and manage their diabetes better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 880 (estimated) |
| Sponsor | University of Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | March 10, 2026 |
| Main results expected | October 2027 |
| Study ends | October 2028 |
| Registry record updated | October 21, 2026 |
| Trial ID | NCT06887049 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (18+) with type 2 diabetes who receive care at a participating clinic and have an A1C above 8% and are not pregnant.
✕Probably not a fit
Patients who are pregnant, have type 1 diabetes, have A1C ≤ 8%, or do not receive care at a participating clinic are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Patients at participating University of Chicago clinics with type 2 diabetes and A1C > 8% will be screened for diabetes distress using a standardized instrument. Clinics will implement the ARISE Learning Community diabetes distress screening and intervention or receive an ARISE Enhanced Care brief training to help clinicians address distress. Outcomes include changes in diabetes distress scores, self-care behaviors, and clinical measures such as A1C. The project emphasizes improving detection and treatment of diabetes-related emotional burden, particularly in populations with higher prevalence of distress.
Why it matters
Potential benefit: If successful, routine screening combined with targeted clinic support could lower diabetes-related distress, improve self-care, and modestly improve blood sugar control.
How similar studies have gone: Previous studies have used standardized diabetes distress screening and some intervention trials have shown reductions in distress, although routine screening is not yet widely implemented.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient at a participating clinic * Type 2 diabetes * Adult (18 years or older) * A1C \> 8% * English- or Spanish-speaking Exclusion Criteria: * Pregnant
Where it's running
-
University of Chicago
Chicago, Illinois, United States Recruiting
Study contacts
- Principal investigator: Arshiya Baig, MD, MPH — University of Chicago
- Study coordinator: Abby Sr. Research Project Manager, MSW
- Email: abigail.durgan@bsd.uchicago.edu
- Phone: 773-834-5646
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Lifestyle change program to help type 2 diabetes go into remission in Pakistan
This study tests whether a structured, plant-predominant lifestyle program can put adults with type 2 diabetes in Lahore, Pakistan into remission for the first six months.
-
Colchicine for preventing cardiovascular disease in adults with type 2 diabetes
A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
-
MWN105 injection in overweight or obese adults you may join
This early-phase trial tests whether MWN105 is safe and tolerable in overweight or obese adults in China, using a placebo comparison.
-
MWN109 tablets in adults with type 2 diabetes mellitus
A phase 2 trial tests MWN109 tablets versus placebo (and against active control semaglutide) to see if the medicine helps adults with type 2 diabetes lower their blood sugar.
-
Brain-heart axis in adults with type 2 diabetes
This study tests how brain activity and heart regulation relate to metabolic status in adults with type 2 diabetes to understand cognitive and functional health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.